Hemoglobin A1c stratifies risk of adverse cardiovascular outcomes in prostate cancer survivors in the UK Biobank: a cohort study

Hemoglobin A1c stratifies risk of adverse cardiovascular outcomes in prostate cancer survivors in the UK Biobank: a cohort study

Abstract Cardiovascular mortality is a major cause of death in prostate cancer (PCa) survivors, yet tools for cardiovascular risk stratification in this population are lacking. Although hemoglobin A1c (HbA1c) is routinely utilized for risk stratification in the general population, the value of HbA1c...

Full description

Saved in:
Bibliographic Details
Main Authors: Adithya K. Yadalam, Alexander C. Razavi, Sagar A. Patel, Chang Liu, Yan V. Sun, Anant Mandawat
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Cardio-Oncology
Subjects:
Prostate cancer
Diabetes
Glycemic control
Hemoglobin A1c
HbA1c
Risk prediction
Online Access:https://doi.org/10.1186/s40959-025-00330-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40959-025-00330-9

Similar Items